On June 1, Medicaid filed concurrent emergency and ordinary regulations making changes to the 340 (B) program and increasing the frequency of permitted dispensing fees for drugs to treat substance abuse disorders to weekly.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Department of Health (LDH) has recently updated its Medicaid COVID-19 vaccine billing schedule adding reimbursement for booster doses for ages 5-11.
Also in Louisiana, LDH requested NACDS remind pharmacies that file claims with Louisiana Medicaid must enroll in Medicaid’s new web‐based provider enrollment portal by June 30, 2022. Any existing Medicaid providers that do not submit an application to initiate the screening process through the new portal will have their claims denied.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Last year, the legislature passed LD 8 which established a prescription drug take-back program in Maine for pharmacies. Pharmacies will have the choice of a secure collection kiosk or offering customers a voucher for a mail-back envelope to properly dispose of unused prescription medications. Drug manufacturers are due to submit a plan to the Maine Department of Environmental Protection (DEP) by July 1, 2022.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
A bill, HB299, allowing pharmacists to administer injectable medications for the treatment of sexually transmitted infections became law last week and will be effective Oct. 1, 2022, pending the adoption of regulations.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Michigan Department of Health and Human Services (MDHSS) has updated the Medicaid PDL (Preferred Drug List) effective 6/1/2022.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
Pharmacy technician licenses expired May 31, 2022. Any technician that did not renew cannot work until the Board office has renewed their license. While the online renewal option ended on May 31st, a paper renewal is available online.
The Department of Commerce and Insurance’s (DCI) Department of Health and Senior Services (DHSS) is opening its application portal for pharmacies to receive and dispense the oral antivirals Paxlovid and Lagevrio (Molnupiravir) to COVID-19 patients with prescriptions.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
On May 13, the Department of Public Health, and Human Services (DPHHS) revised its Provider Revalidation Extension. The following is currently posted on the DPHHS website:
“On December 13, 2021, Montana Healthcare Programs began sending revalidation notices to providers who are due for provider revalidation. The letters specify a due date. Montana Healthcare Programs is extending the required revalidation date for any provider who has received a revalidation notice. This extension is primarily due to a known system issue that is creating challenges for some providers when trying to revalidate. Providers should not attempt to revalidate their provider information at this time. Notices will be posted when the online revalidation feature is working properly. Providers will be given a minimum of 90 days
to complete revalidation activities once notification has occurred.”
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Department of Health and Human Services posted the COVID-19 Pediatric Vaccine Update effective May 17.
Also in Nebraska, the Department of Health and Human Services announced the next COVID-19 Medicaid Provider call will take place on July 6 at noon (Central).
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The New Hampshire legislature passed SB229 and it is on its way to the Governor for his signature. This measure allows licensed or certified pharmacy technicians to administer vaccines under the supervision of a licensed pharmacist. To administer vaccines, pharmacy technicians must be registered with the board and must have completed training that includes hands-on injection techniques and the recognition and treatment of emergency reactions to vaccines.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.